Библиографический список

1. Колхир В. Л., Тюкавкина Н. А., Быков В. А. и др. Диквертин – новое антиоксидантное и капилляропротективное средство // Хим. фарм. журнал. 1995. Т. 9. № 1. С. 61.
2. Недосугова Л. В., Волковой А. К., Рудько И. А. Сравнительная оценка эффективности биофлавоноидов диквертина и танакана в терапии сахарного диабета 2-го типа // Клин. фармакология и терапия. 2000. Т. 9. № 4. С. 65–67.
3. Княжев В. А., Суханов Б. П., Тутельян В. А. Правильное питание: биодобавки, которые вам необходимы. М., 1998. 13 с.
4. Тутельян В. А., Самсонов М. А. Справочник по диетологии. М. : Медицина, 2002. 50 с.
5. Покровский В. И., Романенко Г. А., Княжев В. А. и др. Политика здорового питания. Федеральный и региональный уровни. Новосибирск, 2002. 19 с.
6. Тутельян В. А., Суханов Б. П., Булаев В. М. К вопросу о безопасности биологически активных добавок к пище растительного происхождения // Материалы VII международного съезда «Актуальные проблемы создания новых лекарственных препаратов природного происхождения», 3–5 июля 2003 г., Санкт-Петербург – Пушкин. С. 469–471.
7. Тутельян В. А., Суханов Б. П., Австриевских А. Н., Позняковский В. М. Биологически активные добавки в питании человека : учебник для последипломного образования врачей. Томск, 1999. 38 с.
8. Тутельян В. А., Спиричев В. Б., Суханов Б. П., Кудашева В. А. Микронутриенты в питании здорового и больного человека. Справочное руководство по витаминам и минеральным веществам : руководство для последипломного образования врачей. М. : Колос, 2002. 29 с.
9. Запрометов М. Н. Фенольные соединения растений и их биосинтез / ВИНИТИ. Т. 27. 1988. С. 63–64. (Биологическая химия).
10. Зенков Н. К., Кандалинцева Н. В., Ланкин В. З. и др. Фенольные биооксиданты. Новосибирск, 2003. С. 186–196.
11. Шабров А. В., Дадали В. А., Макаров В. А. Биохимические основы действия микронутриентов пищи. М., 2003.
12. Шиков А. Н., Макаров В. Г., Рыженков В. Е. Растительные масла и масляные экстракты : технология, стандартизация, свойства. М. : Издат. дом «Русский врач», 2004. 264 с.
13. Abraham A. S., Sonnenblick M., Eini M., Shemesh O., Batt A. P. The effect of chromium on established atherosclerotic plaques in rabbits // Am. J. Clin. Nutr. 1980. Vol. 33. № 11. P. 2294–2298.
14. Adzet T. Polyphenolic compounds with biological and pharmacological activity // Herbs. Spices Med. Plants. 1986. Vol. 1. P. 167–184.
15. Anderson R., Roussel A., Zouari N. et al. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus // J. Am. Coll. Nutr. 2001. Vol. 20. № 3. P. 212–218.
16. Anerson I. V., Parry-Billings M., Newsholme E. A. et al. Dieting reduced plasma tryptophan and alters brain 5-HT function in women // Psychol. Ved. 1990. Vol. 20. P. 785–791.
17. Arts I., Hollman P., Feskens E. et al. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Eldery Study // Am. J. Clin. Nutr. 2001. Vol. 74. P. 227–232.
18. Bludell J. E., Burley V. J. Satiation, satiety, and the action of fiber on food intake // Int. J. Jbes. 1987. Vol. 11. P. 9–25.
19. Bock B. C., Kanarek R. B., Aprille J. R. Mineral content of the diet alters sucrose-induced obesity in rats // Physiol Behav. 1995. Vol. 57. P. 659–668.
20. Brady J., Knoeber C. M., Hopper C. L. Pharmacologic action of L-carnitin on hypertriglyceridemia in obese Zucker rats // Metabolism. 1986. Vol. 35. № 6. P. 555–562.
21. Center S. A., Harte J., Watrous D. et al. The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral-carnitine // J. Vet. Intern. Med. 2000. Vol. 14. № 6. P. 598–608.
22. Cos P., Ying L., Calomme M. et al. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers // J. Nat. Prod. 1998. Vol. 61. P. 71–76.
23. Davis C. M., Vincent J. B. Chromium oligopeptide actives insulin receptor tyrosine kinase activity // Biochemistry. 1997. Vol. 36. № 15. P. 4382–4385.
24. De Feudis F. V. Ginkgo biloba Extract (EGb 761): Pharmacological activities and clinical applications. Paris, 1991.
25. De Feudis F. Clinical studies and clinical pharmacology with Egb 761 from Ginkgo biloba extract. Advances in Ginkgo biloba Extract research (eds). 1997. Vol. 6. P. 132–134.
26. Deuchi K., Kanauchi O., Imasato Y., Kobayashi E. Decreasing effect of chitosan on the apparent fat digestibility by rats fed on a high-fat // Biosci. Biotechnol. Biochem. 1994. Vol. 58. P. 1613–1616.
27. Di Carlo G., Mascolo N., Izzo A. et al. Flavonoids: old and new aspects of a class of natural therapeutic drugs // Life Sci. 1999. Vol. 65. № 4. P. 337–353. 28. Dietary Reference Intakes: Applications in Dietary Assessment. Institute of Medicine (IOM). Washington, DC : The Nat. Acad. Press, 2001. 289 p.
28. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Manganese, Molibdenium, Nikel, Silicon, Vanadium and Zinc. Food and Nutrition Board (FNB), Institute of Medicine (IOM). Washington, DC : The Nat. Acad. Press, 2002. 773 p.
29. Dietary Reference Values for Food Energy and Nutrient for the United Kingdom. Report of the panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. HMSO, London, 1991.
30. Dietary Reference Intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Washington, DC : Nat. Acad. Press, 2000. 592 p.
31. Dietary Reference Intakes for vitamin C, vitamin E, selenium and carotenoids. Washington, DC : Ed. Nat. Acad. Press, 2000. 529 p.
32. Food and Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Standing Committee on the scientific evaluation of dietary reference intakes, food and nutrition board, Institute of Medicine. Washington, DC : Nat. Acad. Press, 1997.
33. Fritz I. Carnitine and its role in fatty acids metabolism // Adv. Lipid Res. 1963. Vol. 1. P. 85–334.
34. Fuhrman B., Ben-Yaish L., Attias J. et al. Tomato lycopene and b-carotene inhibit low density lipoprotein oxidation and this effect depends on the lipoprotein vitamin E content // Nutr. Metab. Cardiovasc. Dis. 1997. Vol. 7. № 6. P. 433–443.
35. Health Council of the Netherlands. Dietary reference intakes: energy, proteins, fats and digestible carbohydrates. Publication 2001/19 // The Hague: Health Council of the Netherlands. 2001.
36. Geleijnse J. M., Launer L., Hofman A. et al. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study // Arch. Intern. Med. 1999. Vol. 159. P. 2170–2174.
37. Golub I. Effect of esterin process alfalfa in diabetic patients with hyperlipoproteinaemia upon serum lipid parameters // World Health Organization Clinical Research. 1992.
38. Graham H. N. Green tea composition, consumption, and polyphenol chemistry // Prev. Med. 1992. Vol. 21. P. 334– 350.
39. Han L. K., Takuku, Li J., Kimura Y., Okuda H. Anti-obesity action of oolong tea // Int. J. Obes Relat. Metab. Disord. 1999. № 1. Vol. 23. P. 98–105.
40. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency // Biochem. Pharmacol. 1983. Vol. 32. P. 1141–1148.
41. Hertog M. Flavonos in wine and tea and prevention of coronary heart disease. Paris: Polyphenols 96. Ed. INRA, 1998. P. 117–131.
42. Hobbs C. The Echinacea Handbook. Eclectic Medical Publications, Portland, OR. 1989.
43. Hollman P. C., Katan M. B. Absorption, metabolism and health effects of dietary flavonoids in man // Biomed. Pharmacother. 1997. Vol. 51. № 5. P. 305–310.
44. Jain A. K. et al. Can garlic reduce levels of serum lipids? A controlled clinical study // Am. J. Med. 1993. Vol. 94. P. 632–635.
45. Kalka S. P. Appetite and body weight regulation: is it all in brain // Neuron. 1997. Vol. 19. P. 227–230.
46. Kawada T. et al. Effects of capsaicin in lipid metabolism in rats fed a high fat diet // J. Nutr. 1986. Vol. 116. P. 1272–1278.
47. Kartnig T. Clinical applications of Centella asiatica (L.) // Urb. Herbs Spices Med. Plants. 1988. Vol. 3. P. 146–173.
48. Kendler B. S. Garlic (Allium sativum) and onion (Allium cepa): A review of their relationship to cardiovascular disease // Prev. Med. 1987. Vol. 16. P. 670–685.
49. Kimua Y., Atanabe K., Okuda H. Effects of soluble sodium alginate on cholesterol excretion and glucose tolerance in rats // J. Ethnopharmacol. 1996. Vol. 54. P. 47–54.
50. Knekt P., Kumpulainen J., Jarvinen R. et al. Flavonoid intake and risk of chronic diseases // Ann. Nutr. Metab. 2001. Vol. 45. Suppl. 1. P. 256.
51. Kuhnau J. The flavonoids, a class of semi-essential food components: Their role in humane nutrition // World Rev Nutr. Diet. 1976. Vol. 24. P. 117–191.
52. Law M. Plant sterol and stanol margarines and health // British Med. J. 2000. Vol. 320. P. 861–864.
53. Lee Y. B., Kim Y. S., Ashmore C. R. Antioxidant property in ginger rhizome and its application to meat products // J. Food Sci. 1986. Vol. 51. P. 20–23.
54. Maezaki Y., Tsuji K., Nakagawa Y. et al. Hypocholesterolemic effect of chitosan in adult males // Biosci. Biotechnol. Biochem. 1993. Vol. 57. P. 1439–1444.
55. Milner J. A. Functional foods and health: a US perspective // Brit. J. Nutr. 2002. Vol. 88. Suppl. 2. P. S151–S158.
56. National Hearth Foundation of Australia. A review of the relationship between dietary fat and cardiovascular disease // Australian J. Nutr. Diet. 1999. Vol. 56. Suppl. 4. P. S5–S22.
57. Nijveldt R., Nood E., Hoorn D. et al. Flavonoids: a review of probable mechanisms of action and potential applications // Am. J. Clin. Nutr. 2001. Vol. 74. № 4. P. 418–425.
58. Peterson J., Dwyer J. Flavonoids: dietary occurrence and biochemical activity // Nutr. Res. 1998. Vol. 18. № 12. P. 1995–2018.
59. Pienta K. J., Esper P. S. Risk factors for prostate cancer // Ann. Intern. Med. 1993. Vol. 118. P. 793–803.
60. Preuss H. G., Anderson R. A. Chromium update: examining recent literature 1997–1998 // Curr. Opin. Clin. Nutr. Metab. Care. 1889. № 6. Vol. 1. P. 509–512.
61. Recommended Daily Amounts of Vitamin and Minerals in Europe // Nutrition Abstracts and Revievs, Series A. 1990. Vol. 60. № 10.
62. Riales R., Albrik M. J. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men // Am. J. Clin. Nutr. 1981. Vol. 34. P. 2670–2678.
63. Roberfroid M. B. Global view on functional foods: European perspectives // Brit. J. Nutr. 2002. Vol. 88. Suppl. 2. P. S133–S138.
64. Salvadori M. C., Rieser E. V., Ribeiro Neto L. V., Nascimento E. S. Determination of xanthines by high-performance liquid chromatography and thn-layer chromatography in horse urine after ingestion of Guarana powder // Analyst. 1994. Vol. 119. ? 12. P. 2701–2703.
65. Schwitters B., Masquelier J. OPC in practice: biflavanols and their application // Alfa Omega. Rome, 1993.
66. Sha A. K., Vavvas D., Kurowski T. G. et al. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle // Am. J. Physiol. 1997. Vol. 272. P. 641–648.
67. Taussig S. et al. Bromelain, a proteolytic enzyme and its clinical application. A review // Hiroshima J. Med. Sci. 1975. Vol. 24. P. 185–193.
68. Trace elements in human nutrition and health. Geneva: WHO, 1996. 343 p.
69. Wang Q., Bing, Al-Barazanji K. et al. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat // Diabetes. 1997. Vol. 46. P. 335–341.
70. Watanabe T. et al. Capsaicin, a pungent principle of hot red pepper, evokes catecholamine secretion from the adrenal medulla of anesthetized rats // Biochem. Biophys. Res. Comm. 1987. Vol. 142. P. 259–264.
71. Yaamoto M., Shimura S., Itoh Y. et al. Anti-obesity effects of lipase inhibitor CT-11, an extract from edible herbs, Nomame Herba, on rats fad a high-fat diet // Int. J. Obes. Relat. Metab. Disord. 2000. Vol. 24. ? 6. P. 758–764.